StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Medifast pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Medifast's pe ratio was 37.6× on Oct 31, 2025, against 3.5× a year earlier. Over the last 5 years it ranged from 3.0× to 75.6×, with a median of 12.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 202537.6×+10.9
2024Dec 31, 202426.7×+20.6
2023Dec 29, 20236.1×−2.6
2022Dec 30, 20228.8×−6.9
2021Dec 31, 202115.7×−8.9
2020Dec 31, 202024.6×+6.5
2019Dec 31, 201918.1×−13.9
2018Dec 31, 201832.0×−2.4
2017Dec 29, 201734.4×+6.4
2016Dec 30, 201627.9×−1.0
2015Dec 31, 201528.9×+8.8
2014Dec 31, 201420.1×+2.6
2013Dec 31, 201317.5×−6.7
2012Dec 31, 201224.2×+14.7
2011Dec 30, 20119.5×−28.0
2010Dec 31, 201037.5×–

More Medifast figures

See a number that looks wrong?